These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26260271)

  • 1. Phenylbutyrate-a pan-HDAC inhibitor-suppresses proliferation of glioblastoma LN-229 cell line.
    Kusaczuk M; Krętowski R; Bartoszewicz M; Cechowska-Pasko M
    Tumour Biol; 2016 Jan; 37(1):931-42. PubMed ID: 26260271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and cellular effects of a novel hydroxamate-based HDAC inhibitor - belinostat - in glioblastoma cell lines: a preliminary report.
    Kusaczuk M; Krętowski R; Stypułkowska A; Cechowska-Pasko M
    Invest New Drugs; 2016 Oct; 34(5):552-64. PubMed ID: 27468826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Krüppel-like factor 9 and histone deacetylase inhibitors synergistically induce cell death in glioblastoma stem-like cells.
    Tung B; Ma D; Wang S; Oyinlade O; Laterra J; Ying M; Lv SQ; Wei S; Xia S
    BMC Cancer; 2018 Oct; 18(1):1025. PubMed ID: 30348136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brazilin induces apoptosis and G2/M arrest via inactivation of histone deacetylase in multiple myeloma U266 cells.
    Kim B; Kim SH; Jeong SJ; Sohn EJ; Jung JH; Lee MH; Kim SH
    J Agric Food Chem; 2012 Oct; 60(39):9882-9. PubMed ID: 22967175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylbutyrate sensitizes human glioblastoma cells lacking wild-type p53 function to ionizing radiation.
    Lopez CA; Feng FY; Herman JM; Nyati MK; Lawrence TS; Ljungman M
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):214-20. PubMed ID: 17707275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel class I histone deacetylase inhibitor, I-7ab, induces apoptosis and arrests cell cycle progression in human colorectal cancer cells.
    Yang L; Liang Q; Shen K; Ma L; An N; Deng W; Fei Z; Liu J
    Biomed Pharmacother; 2015 Apr; 71():70-8. PubMed ID: 25960218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor platinum(IV) derivatives of carboplatin and the histone deacetylase inhibitor 4-phenylbutyric acid.
    Almotairy ARZ; Gandin V; Morrison L; Marzano C; Montagner D; Erxleben A
    J Inorg Biochem; 2017 Dec; 177():1-7. PubMed ID: 28918353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel histone deacetylase (HDAC) inhibitor MHY219 induces apoptosis via up-regulation of androgen receptor expression in human prostate cancer cells.
    Patra N; De U; Kim TH; Lee YJ; Ahn MY; Kim ND; Yoon JH; Choi WS; Moon HR; Lee BM; Kim HS
    Biomed Pharmacother; 2013 Jun; 67(5):407-15. PubMed ID: 23583193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G(1) Phase growth arrest and induction of p21(Waf1/Cip1/Sdi1) in IB3-1 cells treated with 4-sodium phenylbutyrate.
    McGrath-Morrow SA; Stahl JL
    J Pharmacol Exp Ther; 2000 Sep; 294(3):941-7. PubMed ID: 10945844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel histone deacetylase inhibitor AR-42 exhibits antitumor activity in pancreatic cancer cells by affecting multiple biochemical pathways.
    Chen YJ; Wang WH; Wu WY; Hsu CC; Wei LR; Wang SF; Hsu YW; Liaw CC; Tsai WC
    PLoS One; 2017; 12(8):e0183368. PubMed ID: 28829799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Phenybutyric acid promotes gastric cancer cell migration via histone deacetylase inhibition-mediated HER3/HER4 up-regulation.
    Shi X; Zheng C; Li C; Hou K; Wang X; Yang Z; Liu C; Liu Y; Che X; Qu X
    Cell Biol Int; 2018 Jan; 42(1):53-62. PubMed ID: 28851073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superior activity of a new histone deacetylase inhibitor (ZYJ-34c) in inhibiting growth of human leukemia cells by inducing p21WAF1 expression and cell cycle arrest.
    Yang H; Xu W; Li Y; Lan P; Zhang J; Zhang Y; Zhang C
    Anticancer Drugs; 2014 Aug; 25(7):767-77. PubMed ID: 24686006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effects of (S)-HDAC42, a phenylbutyrate-derived histone deacetylase inhibitor, in multiple myeloma cells.
    Bai LY; Omar HA; Chiu CF; Chi ZP; Hu JL; Weng JR
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):489-96. PubMed ID: 21072520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginsenoside 20(s)-Rh2 as potent natural histone deacetylase inhibitors suppressing the growth of human leukemia cells.
    Liu ZH; Li J; Xia J; Jiang R; Zuo GW; Li XP; Chen Y; Xiong W; Chen DL
    Chem Biol Interact; 2015 Dec; 242():227-34. PubMed ID: 26482938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cysteinyl leukotriene receptor antagonists induce apoptosis and inhibit proliferation of human glioblastoma cells by downregulating B-cell lymphoma 2 and inducing cell cycle arrest.
    Piromkraipak P; Parakaw T; Phuagkhaopong S; Srihirun S; Chongthammakun S; Chaithirayanon K; Vivithanaporn P
    Can J Physiol Pharmacol; 2018 Aug; 96(8):798-806. PubMed ID: 29726704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways.
    Meng J; Zhang HH; Zhou CX; Li C; Zhang F; Mei QB
    Oncol Rep; 2012 Jul; 28(1):384-8. PubMed ID: 22552631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitor 4-phenylbutyrate suppresses GAPDH mRNA expression in glioma cells.
    Appelskog IB; Ammerpohl O; Svechnikova IG; Lui WO; Almqvist PM; Ekström TJ
    Int J Oncol; 2004 Jun; 24(6):1419-25. PubMed ID: 15138583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trastuzumab enhances the anti-tumor effects of the histone deacetylase inhibitor sodium butyrate on a HER2-overexpressing breast cancer cell line.
    Chen W; Wei F; Xu J; Wang Y; Chen L; Wang J; Guan X
    Int J Mol Med; 2011 Dec; 28(6):985-91. PubMed ID: 21887460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDAC inhibitors effectively induce cell type-specific differentiation in human glioblastoma cell lines of different origin.
    Svechnikova I; Almqvist PM; Ekström TJ
    Int J Oncol; 2008 Apr; 32(4):821-7. PubMed ID: 18360709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PBA Preferentially Impairs Cell Survival of Glioblastomas Carrying mutp53 by Reducing Its Expression Level, Stabilizing wtp53, Downregulating the Mevalonate Kinase and Dysregulating UPR.
    Romeo MA; Gilardini Montani MS; Benedetti R; Garufi A; D'Orazi G; Cirone M
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32290231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.